NaturalPedia > Avastin

Quotes about Avastin from the world's top natural health / natural living authors

 Email this page to a friend   |  Click here for FREE email alerts

"The answer may lie in the fact that avastin produces some of the worst side-effects a drug can produce, and that is good business. The thousands of doctors, hospital administrators, health agencies that endorsed this killer drug either fell for the scam, or welcomed it." - Andreas Moritz, Cancer Is Not A Disease - It's A Survival Mechanism (Get the book.) "An FDA review of the drug concluded that avastin did not significantly lengthen the lives of patients. On the contrary, it killed a number of patients. An article published in the New York Times (5 July, 2008) raised some troubling questions about this drug. It says, "What does it mean to say the drug works? Is slowing the growth of tumors enough if life is not significantly prolonged or improved? How much evidence should there be before billions of dollars are spent on a drug? And when should cost be factored into the equation?" - Andreas Moritz, Cancer Is Not A Disease - It's A Survival Mechanism (Get the book.) "As a result of the high cost of Herceptin and avastin, I am going to hit my lifetime max of $1 million on my health insurance before the end of 2007." Beware of arthritis drugs Do Arthritis Drugs Cause Cancer? This is the title of an article published in the New York Times, June 5, 2008. As stated in the article, the FDA has received reports of 30 cases of cancer among children and young adults treated with drugs for rheumatoid arthritis psoriasis, Crohn's disease, and other immune system diseases. The drugs involved are: 1. Enbrel, sold by Amgen and Wyeth 2." - Andreas Moritz, Cancer Is Not A Disease - It's A Survival Mechanism (Get the book.) "This is a no-brainer for drug makers since FDA approval is granted to anti-cancer drugs based on response rates that are at best in the 10-20 percent range (as happened, for example, with the popular drugs, avastin, Erbitux, and Iressa). In addition, the "success" of most clinical cancer studies is measured by tumor shrinkage instead of mortality rate. In other words, even if most of the subjects died but had their tumors shrunk through aggressive treatments, the study would be hailed as a great success and a medical breakthrough." - Andreas Moritz, Cancer Is Not A Disease - It's A Survival Mechanism (Get the book.)

"In 2006 a drug called avastin could cost cancer patients as much as $100,000 a year, depending on the dose and type of cancer. When doctors added a medicine called Erbitux to the standard chemotherapy regimen for patients with advanced colon cancer, the cost of treatment rose to as much as $250,000. For patients with a rare disorder called Gaucher's disease, the needed drug, Cerezyme, could cost more than $600,000 a year. The pharmaceutical industry had long argued that its high prices were needed to cover the cost of discovering new medicines." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"Many anti-angiogenic drugs have been developed and are undergoing clinical trials. avastin is one such drug approved in the United States as a treatment for cancer patients. Its side effects include high blood pressure and an increased risk of blood clots. Used as a complementary therapy with chemotherapy, anti-angiogenic drugs may be effective as a cancer treatment. Research has shown that this type of therapy is useful in prolonging survival and preventing growth of cancer tumors rather than in shrinking the tumor." - Freedom Press, Natural Cancer Cures: The Definitive Guide to Using Dietary Supplements to Fight and Prevent Cancer (Get the book.)

"I u on Regimen Universal dietary and supplement regimens to successfully fight cancer drugs like Herceptin, avastin, Erbitux that temporarily infuse targeted antibodies into a tumor. Anticancer mechanisms within your own body can be activated to put a stop to cancer in a continual manner that exceeds that of anti-cancer drugs. Cancer authorities now speak of universal mechanisms that can be manipulated to block the growth, spread and recurrence of cancer." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"Genentech, for example, has developed a number of new cancer drugs, including avastin. In a letter to stockholders in its 2004 annual report, CEO Arthur D. Levinson boasted how total operating revenues had increased to $4-6 billion, more than doubling since 2001. 'Out financial position also remains strong, with approximately $2.8 billion in unrestricted cash and investments,' he added.42 One of the reasons Genentech, which is now 60% owned by Roche of Switzerland, has done well is that it takes risks to nurture cteativity." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "He went on to present positive findings in kidney cancer, a traditionally hard tumour to treat, using avastin and Tarceva. 'The rationale was to try to build on the biology by blocking more than one signalling molecule within these cells,' he said.25 That same combination of drugs has also been shown to be effective in non-small cell lung cancer. So far the improvements are modest but it is early days. If they are shown to stop progression of the tumour for 18-24 months rather than 12-14 months, says Hainsworth, they will be hard to resist." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "For all the hype surrounding avastin, it only extended the life of patients for five months more than those taking standard chemotherapy,' said Dyer.11 As such, the drugs are proving to be as much a lifeline to the industry as to the people they treat. The health gains may not be great, being measured in months rather than years, but the drugs do extend life and that's what matters most in medicine. Besides, costs naturally come down once the patent term has expired, and for now they are delivering results, the importance of which cannot be overstated." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "Another kind of drug, avastin, again initially for colon cancer, blocks a protein that encourages blood vessels that grow specifically to feed a tumour, thus starving it of another source A bit of a lottery of growth. The genius of yet a third kind is represented by Glivec, which identifies, and then reverses, a genetic flaw which, in this case, turns on an enzyme that causes a rare form of blood cancer. These are real advances and doctors love them. They don't care what they cost because the results in some patients are fantastic and, on the whole, they are well tolerated." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

"Avastin (bevacizumab) for colorectal cancer can cost $4,400 per month. Revlimid (lenalidomide), a treatment for multiple myeloma, could cost more than $70,000 per year. And Erbitux (cetuximab) for head and neck or colorectal cancer might exceed $110,000 annually. Two decades ago we spoke with a drug company insider. This former executive related a top-level meeting in which this question was raised: "If you found a cure for cancer, what would you charge for it?" The executive who was being grilled admitted that they would almost have to give it away." - Joe Graedon, M.S. and Teresa Graedon, Ph.D., Best Choices From the People's Pharmacy (Get the book.)

"J Clinical Oncology 9: 286-94, 1991 ] avastin, the newly introduced anti-angiogenesis drug, carries a serious risk of blood clots, its manufacturer has warned. [American Cancer Society News Center, August 17, 2004] The annual incidence of blood clots (venous thromboembolism) is not only directly life threatening if they enter the lungs or block circulation to the brain or heart, but they also portend a poor prognosis for cancer patients. Only 12% survive beyond a year if they develop clots. An estimated 11-20% of cancer patients on chemotherapy develop blood clots. [Thrombosis Research Dec." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.) "Worldwide sales of avastin reached $1.3 billion in 2005 and the halt in the clinical study hardly made an impact upon sales, which surpassed $500 million in the first three months of 2006. [Pharmaceutical Business Review Online, May 23, 2006] Radiation treatment In North America there is an emphasis on postoperative radiation treatment and there is evidence that this is more effective when combined with 5-FU-based chemotherapy. The combination treatment has demonstrated a reduction in local recurrence from 8% to 2%. However, most treated patients experience no benefit." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.) "However, avastin offers, at best, only a few months more of life. Ethics problems have riddled the FDA, and the National Institutes of Health, and it's obvious that cancer patients are just pawns while researchers and drug companies make billions of dollars for trivial improvements in survival rates. Cancer patients and their families have no time to investigate all this. They can only accept what their doctors tell them. They have no idea they are being shepherded to a dead end street." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"The Associated Press reports that the drug avastin increases the risk of heart ailments including chest pain, strokes, mini-strokes, and heart attacks. This means that this drug can kill the people who take it. It is interesting to note that every article that I am reporting on here that talks about drugs also has a heavy emphasis on the stock price and how this news is affecting shareholder value. I cannot emphasize enough that drug companies are publicly traded companies whose only objective is to make profit. They do not want to cure or prevent disease." - Kevin Trudeau, Natural Cures They Don't Want You to Know About (Get the book.)

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.